Integra LifeSciences Holdings (IART)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	1,395,820	1,419,620	1,333,410	1,337,210	1,300,490	1,381,140	1,385,540	1,389,930	1,388,680	1,387,430	1,386,180	1,484,910	1,408,220	1,414,000	1,472,320	1,478,190	1,198,560	1,274,050	1,204,540	1,205,020
Total assets	US$ in thousands	3,781,990	3,739,370	3,777,600	3,742,400	3,889,760	3,807,010	3,752,860	3,672,000	3,782,380	3,774,460	3,712,790	3,741,550	3,615,140	3,453,520	3,391,760	3,447,560	3,303,240	3,346,580	3,290,410	3,205,710
Debt-to-assets ratio		0.37	0.38	0.35	0.36	0.33	0.36	0.37	0.38	0.37	0.37	0.37	0.40	0.39	0.41	0.43	0.43	0.36	0.38	0.37	0.38

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,395,820K ÷ $3,781,990K
= 0.37

The debt-to-assets ratio of Integra Lifesciences Holdings Corp has shown some fluctuation over the past eight quarters. Generally, a higher debt-to-assets ratio indicates higher financial risk as it signifies a greater reliance on debt financing.

In Q4 2023 and Q3 2023, the ratio remained constant at 0.40, indicating that 40% of the company's assets were financed through debt. This level of debt could be considered moderate, as it suggests a balanced capital structure.

In Q2 2023 and Q1 2023, the ratio decreased slightly to 0.38, suggesting a slightly lower reliance on debt compared to the previous quarters. This could indicate improved financial stability or a shift towards utilizing more equity financing.

Looking further back, in Q4 2022 and Q3 2022, the ratio was 0.37 and 0.41 respectively, showing some volatility. This fluctuation could indicate changes in the company's capital structure or financial strategy during those periods.

Overall, Integra Lifesciences Holdings Corp's debt-to-assets ratio has remained relatively stable around the 0.40 mark in recent quarters, indicating a moderate level of debt relative to its total assets. Investors and stakeholders may want to monitor future trends in this ratio to assess the company's financial health and risk profile.